# MRK PDUFA Calendar: FDA Decision Dates & Catalyst Timeline

Canonical URL: https://biopharmsignal.com/pdufa-calendar/MRK
Company: Merck

BioPharmSignal tracks active PDUFA and FDA decision milestones associated with MRK.

## MRK PDUFA Milestones

- 2024-01-12 — FDA Approval — FDA approved application. FDA recorded approval of KEYTRUDA on January 12, 2024. This list-only historical record is sourced from the official FDA applicatio...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-bla-125514-suppl-147.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2024/january (January 2024)
- 2024-01-25 — FDA Approval — FDA approved application. FDA recorded approval of KEYTRUDA on January 25, 2024. This list-only historical record is sourced from the official FDA applicatio...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-bla-125514-suppl-124.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2024/january (January 2024)
- 2024-03-26 — FDA Approval — FDA approved application. FDA recorded approval of WINREVAIR on March 26, 2024. This list-only historical record is sourced from the official FDA application...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761363
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/winrevair-bla-761363-orig-1.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2024/march (March 2024)
- 2024-06-07 — FDA Approval — FDA approved application. FDA recorded approval of KEYTRUDA on June 7, 2024. This list-only historical record is sourced from the official FDA application da...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-bla-125514-suppl-154.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2024/june (June 2024)
- 2024-06-17 — FDA Approval — FDA approved application. FDA recorded approval of KEYTRUDA on June 17, 2024. This list-only historical record is sourced from the official FDA application d...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-bla-125514-suppl-155.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2024/june (June 2024)
- 2024-08-07 — FDA Approval — FDA approved application. FDA recorded approval of KEYTRUDA on August 7, 2024. This list-only historical record is sourced from the official FDA application...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-bla-125514-suppl-157.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2024/august (August 2024)
- 2024-08-30 — FDA Approval — FDA approved application. FDA recorded approval of PREVYMIS on August 30, 2024. This list-only historical record is sourced from the official FDA application...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209939
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/prevymis-nda-209939-suppl-13.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2024/august (August 2024)
- 2024-09-17 — FDA Approval — FDA approved application. FDA recorded approval of KEYTRUDA on September 17, 2024. This list-only historical record is sourced from the official FDA applicat...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-bla-125514-suppl-161.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2024/september (September 2024)
- 2024-12-11 — FDA Approval — FDA approved application. FDA recorded approval of KEYTRUDA on December 11, 2024. This list-only historical record is sourced from the official FDA applicati...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-bla-125514-suppl-162.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2024/december (December 2024)
- 2024-12-12 — FDA Approval — FDA approved application. FDA recorded approval of BRIDION on December 12, 2024. This list-only historical record is sourced from the official FDA applicatio...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22225
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/bridion-nda-022225-suppl-14.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2024/december (December 2024)
- 2025-01-28 — FDA Approval — FDA approved application. FDA recorded approval of KEYTRUDA on January 28, 2025. This list-only historical record is sourced from the official FDA applicatio...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-bla-125514-suppl-172.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2025/january (January 2025)
- 2025-03-19 — FDA Approval — FDA approved application. FDA recorded approval of KEYTRUDA on March 19, 2025. This list-only historical record is sourced from the official FDA application...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-bla-125514-suppl-170.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2025/march (March 2025)
- 2025-04-15 — FDA Approval — FDA approved application. FDA recorded approval of WELIREG on April 15, 2025. This list-only historical record is sourced from the official FDA application d...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215383
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/welireg-nda-215383-suppl-11.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2025/april (April 2025)
- 2025-04-21 — FDA Approval — FDA approved application. FDA recorded approval of KEYTRUDA on April 21, 2025. This list-only historical record is sourced from the official FDA application...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-bla-125514-suppl-174.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2025/april (April 2025)
- 2025-05-14 — FDA Approval — FDA approved application. FDA recorded approval of WELIREG on May 14, 2025. This list-only historical record is sourced from the official FDA application dat...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215383
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/welireg-nda-215383-suppl-12.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2025/may (May 2025)
- 2025-05-22 — FDA Approval — FDA approved application. FDA recorded approval of KEYTRUDA on May 22, 2025. This list-only historical record is sourced from the official FDA application da...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-bla-125514-suppl-182.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2025/may (May 2025)
- 2025-06-03 — FDA Approval — FDA approved application. FDA recorded approval of KEYTRUDA on June 3, 2025. This list-only historical record is sourced from the official FDA application da...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-bla-125514-suppl-173.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2025/june (June 2025)
- 2025-06-06 — FDA Approval — FDA approved application. FDA recorded approval of KEYTRUDA on June 6, 2025. This list-only historical record is sourced from the official FDA application da...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-bla-125514-suppl-183.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2025/june (June 2025)
- 2025-06-09 — FDA Approval — FDA approved application. FDA recorded approval of ENFLONSIA on June 9, 2025. This list-only historical record is sourced from the official FDA application d...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761432
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/enflonsia-bla-761432-orig-1.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2025/june (June 2025)
- 2025-06-12 — FDA Approval — FDA approved application. FDA recorded approval of KEYTRUDA on June 12, 2025. This list-only historical record is sourced from the official FDA application d...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-bla-125514-suppl-180.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2025/june (June 2025)
- 2025-07-24 — FDA Approval — FDA approved application. FDA recorded approval of KEYTRUDA on July 24, 2025. This list-only historical record is sourced from the official FDA application d...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-bla-125514-suppl-178.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2025/july (July 2025)
- 2025-09-19 — FDA Approval — FDA approved application. FDA recorded approval of KEYTRUDA QLEX on September 19, 2025. This list-only historical record is sourced from the official FDA app...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761467
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-qlex-bla-761467-orig-1.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2025/september (September 2025)
- 2025-10-15 — FDA Approval — FDA approved application. FDA recorded approval of FDA application BLA 761495 on October 15, 2025. This list-only historical record is sourced from the offic...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761495
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/fda-application-bla-761495-bla-761495-orig-1.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2025/october (October 2025)
- 2025-10-24 — FDA Approval — FDA approved application. FDA recorded approval of WINREVAIR on October 24, 2025. This list-only historical record is sourced from the official FDA applicati...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761363
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/winrevair-bla-761363-suppl-7.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2025/october (October 2025)
- 2025-11-21 — FDA Approval — FDA approved application. FDA recorded approval of KEYTRUDA on November 21, 2025. This list-only historical record is sourced from the official FDA applicati...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-bla-125514-suppl-188.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2025/november (November 2025)
- 2025-11-21 — FDA Approval — FDA approved application. FDA recorded approval of KEYTRUDA QLEX on November 21, 2025. This list-only historical record is sourced from the official FDA appl...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761467
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-qlex-bla-761467-suppl-1.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2025/november (November 2025)
- 2025-12-09 — FDA Approval — FDA approved application. FDA recorded approval of RECARBRIO on December 9, 2025. This list-only historical record is sourced from the official FDA applicati...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212819
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/recarbrio-nda-212819-suppl-8.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2025/december (December 2025)
- 2026-01-27 — FDA Approval — FDA approved application. FDA recorded approval of NOXAFIL on January 27, 2026. This list-only historical record is sourced from the official FDA application...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205053
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/noxafil-nda-205053-suppl-18.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2026/january (January 2026)
- 2026-01-27 — FDA Approval — FDA approved application. FDA recorded approval of NOXAFIL POWDERMIX KIT on January 27, 2026. This list-only historical record is sourced from the official F...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214770
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/noxafil-powdermix-kit-nda-214770-suppl-9.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2026/january (January 2026)
- 2026-02-10 — FDA Approval — FDA approved application. FDA recorded approval of KEYTRUDA on February 10, 2026. This list-only historical record is sourced from the official FDA applicati...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-bla-125514-suppl-186.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2026/february (February 2026)
- 2026-02-10 — FDA Approval — FDA approved application. FDA recorded approval of KEYTRUDA QLEX on February 10, 2026. This list-only historical record is sourced from the official FDA appl...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761467
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-qlex-bla-761467-suppl-2.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2026/february (February 2026)
- 2026-04-20 — FDA Approval — FDA approved application. FDA recorded approval of IDVYNSO on April 20, 2026. This list-only historical record is sourced from the official FDA application d...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216964
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/idvynso-idvynso-nda.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2026/april (April 2026)
- 2026-04-24 — FDA Approval — FDA approved application. FDA recorded approval of KEYTRUDA QLEX on April 24, 2026. This list-only historical record is sourced from the official FDA applica...
  Company: Merck
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761467
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-qlex-bla-761467-suppl-3.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2026/april (April 2026)
- 2026-06-19 — PDUFA — FDA approved WELIREG plus KEYTRUDA. FDA approved belzutifan with pembrolizumab or KEYTRUDA QLEX as adjuvant treatment for adults with clear cell renal cell c...
  Company: Merck
  Source: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-belzutifan-pembrolizumab-adjuvant-treatment-renal-cell-carcinoma
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/welireg-keytruda-adjuvant-clear-cell-rcc.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2026/june (June 2026)
- 2026-08-17 — PDUFA — Original PDUFA date superseded by early approval. FDA had assigned August 17 as the target action date for the supplemental applications. The agency approved...
  Company: Merck
  Source: https://www.merck.com/news/fda-grants-priority-review-for-keytruda-pembrolizumab-and-keytruda-qlex-pembrolizumab-and-berahyaluronidase-alfa-pmph-each-with-padcev-enfortumab-vedotin-ejfv-for-cisplati/
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/keytruda-padcev-muscle-invasive-bladder-cancer.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2026/august (August 2026)
- 2026-09-21 — PDUFA — FDA decision expected. FDA assigned a September 21, 2026 PDUFA date to the HYPERION-based WINREVAIR label-update application.
  Company: Merck
  Source: https://www.merck.com/news/merck-highlights-progress-advancing-broad-diverse-pipeline/
  Event detail: https://biopharmsignal.com/pdufa-calendar/MRK/winrevair-recently-diagnosed-pah-hyperion.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2026/september (September 2026)

## Related Pages

- Company page: https://biopharmsignal.com/company/MRK
- Interactive PDUFA Calendar: https://biopharmsignal.com/pdufa-calendar

## FAQ

### What does the MRK PDUFA calendar show?

It shows active PDUFA and FDA decision milestones associated with MRK, including decision dates, application stage, and summary details when available.
### Where can I find more context for MRK?

Use the BioPharmSignal company page for MRK to read related news, stock data, sector context, and company-specific updates.
### Are these dates investment advice?

No. PDUFA dates are research inputs, not investment recommendations. Always review primary sources and understand the clinical and regulatory context.
